Clinical Trial Update: Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Otelixizumab in new-onset autoimmune type 1 diabetes patients (Phase 1/Phase 2) completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Otelixizumab (otelixizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-24